Published in Lancet on July 10, 1999
Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases. PLoS Negl Trop Dis (2008) 2.44
Weighing up disability. Lancet (1999) 2.32
Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database. PLoS Med (2012) 1.62
New disability weights for the global burden of disease. Bull World Health Organ (2010) 1.59
Cost-effectiveness of an essential mental health intervention package in Nigeria. World Psychiatry (2007) 1.57
Comparative impact assessment of child pneumonia interventions. Bull World Health Organ (2009) 1.49
Assessing disability weights based on the responses of 30,660 people from four European countries. Popul Health Metr (2015) 1.42
WHO's ICF and functional status information in health records. Health Care Financ Rev (2003) 1.34
Valuation of health states in the US study to establish disability weights: lessons from the literature. Int J Methods Psychiatr Res (2010) 1.15
Cross-national agreement on disability weights: the European Disability Weights Project. Popul Health Metr (2003) 1.12
Review of disability weight studies: comparison of methodological choices and values. Popul Health Metr (2014) 1.11
The global burden of disease disability weights. Lancet (2000) 1.11
Burden of disease associated with alcohol use disorders in the United States. Alcohol Clin Exp Res (2014) 1.09
A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. Hum Mol Genet (2010) 1.08
Disability Weights Measurement for 228 Causes of Disease in the Korean Burden of Disease Study 2012. J Korean Med Sci (2016) 1.05
Disability weights in the global burden of disease 2010 study: two steps forward, one step back? Bull World Health Organ (2014) 1.03
Metabolome in schizophrenia and other psychotic disorders: a general population-based study. Genome Med (2011) 0.98
Improved and standardized method for assessing years lived with disability after injury. Bull World Health Organ (2012) 0.93
Disability adjusted life years and minimal disease: application of a preference-based relevance criterion to rank enteric pathogens. Popul Health Metr (2008) 0.90
Long term outcome after poliomyelitis in different health and social conditions. J Epidemiol Community Health (2003) 0.89
Whose priorities count? Comparison of community-identified health problems and Burden-of-Disease-assessed health priorities in a district in Uganda. Health Expect (2002) 0.86
Impact of inappropriate drug use on physical performance among a frail elderly population living in the community. Eur J Clin Pharmacol (2007) 0.85
Subnational burden of disease studies: Mexico leads the way. PLoS Med (2008) 0.85
Meta-analysis of infectious agents and depression. Sci Rep (2014) 0.83
Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa. J Acquir Immune Defic Syndr (2016) 0.83
Disability weights for cancers in Korea. J Korean Med Sci (2013) 0.82
Decomposing cross-country differences in quality adjusted life expectancy: the impact of value sets. Popul Health Metr (2011) 0.82
Estimation of utility weights for human papilloma virus-related health states according to disease severity. Health Qual Life Outcomes (2016) 0.81
Three amino acids in the D2 dopamine receptor regulate selective ligand function and affinity. J Neurochem (2009) 0.80
Risk perception and priority setting for intervention among hepatitis C virus and environmental risks: a cross-sectional survey in the Cairo community. BMC Public Health (2010) 0.79
Schizophrenia and periodontal disease: An oro-neural connection? A cross-sectional epidemiological study. J Indian Soc Periodontol (2014) 0.78
Early intervention for first episode psychosis: worldwide burden of psychosis is not as severe as suggested. BMJ (2004) 0.77
Associations between child disabilities and caregiver discipline and violence in low- and middle-income countries. Child Dev (2013) 0.77
Hidden costs: The ethics of cost-effectiveness analyses for health interventions in resource-limited settings. Glob Public Health (2016) 0.77
The psychiatric inpatient physical health assessment sheet (PIPHAS): a useful tool to improve the speed, efficiency, and documentation of physical examination in new psychiatric inpatients. BMJ Qual Improv Rep (2015) 0.75
Translating genomic research into care for people with schizophrenia in China. Schizophr Res (2011) 0.75
Drug treatment developments in schizophrenia and bipolar mania: latest evidence and clinical usefulness. Ther Adv Chronic Dis (2012) 0.75
Utilities of the post-anesthesia state derived by the standard gamble method in surgical patients. BMC Med Inform Decis Mak (2006) 0.75
Estimation of Disability Weights in the General Population of South Korea Using a Paired Comparison. PLoS One (2016) 0.75
Sexual dysfunction and hyperprolactinemia in male psychotic inpatients: a cross-sectional study. Adv Urol (2011) 0.75
Scale up services for mental disorders: a call for action. Lancet (2007) 10.32
The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40
Global burden of depressive disorders in the year 2000. Br J Psychiatry (2004) 9.25
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
Systematic gain-of-function genetics in Drosophila. Development (1998) 4.71
Interventions to reduce harm associated with adolescent substance use. Lancet (2007) 3.98
Defining substance use disorders: do we really need more than heavy use? Alcohol Alcohol (2013) 3.72
Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way. Diabetologia (2006) 3.28
Mental health research priorities in low- and middle-income countries of Africa, Asia, Latin America and the Caribbean. Br J Psychiatry (2009) 3.11
Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study. Addiction (1999) 3.00
Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry (2001) 2.67
Characteristics of binge drinkers in Europe. Soc Sci Med (2004) 2.63
WHO Study on the reliability and validity of the alcohol and drug use disorder instruments: overview of methods and results. Drug Alcohol Depend (1997) 2.59
Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage. J Biol Chem (2000) 2.44
Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A (1999) 2.42
The more you drink, the harder you fall: a systematic review and meta-analysis of how acute alcohol consumption and injury or collision risk increase together. Drug Alcohol Depend (2010) 2.37
Pet birds as an independent risk factor for lung cancer: case-control study. BMJ (1992) 2.34
The E1B 19K/Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis. J Exp Med (1997) 2.33
Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J Cell Biol (2000) 2.22
Social costs of untreated opioid dependence. J Urban Health (2000) 2.18
The International Classification of Functioning, Disability and Health: a new tool for understanding disability and health. Disabil Rehabil (2003) 2.14
Models of disablement, universalism and the international classification of impairments, disabilities and handicaps. Soc Sci Med (1999) 2.11
Reliability of the Romanian version of the alcohol module of the WHO Alcohol Use Disorder and Associated Disabilities: Interview Schedule --Alcohol/Drug-Revised. Eur Addict Res (1998) 2.09
Light alcohol drinking and cancer: a meta-analysis. Ann Oncol (2012) 2.04
Sore throat consultations in general practice prior to tonsillectomy among eight hundred and sixty-three children in England: is this in accordance with the SIGN guidelines? Clin Otolaryngol (2013) 2.02
Morbidity and mortality attributable to alcohol, tobacco, and illicit drug use in Canada. Am J Public Health (1999) 1.99
An overview of illegal opioid use and health services utilization in Canada. Public Health (2006) 1.97
Contribution of drinking patterns to differences in rates of alcohol related problems between three urban populations. J Epidemiol Community Health (2004) 1.91
Application of the International Classification of Functioning, Disability and Health (ICF) in clinical practice. Disabil Rehabil (2002) 1.91
Clinical assessment compared with breathalyser readings in the emergency room: concordance of ICD-10 Y90 and Y91 codes. Emerg Med J (2005) 1.87
The case for a heroin substitution treatment trial in Canada. Can J Public Health (1998) 1.86
Comparison of three videolaryngoscopes: Pentax Airway Scope, C-MAC, Glidescope vs the Macintosh laryngoscope for tracheal intubation. Anaesthesia (2010) 1.85
Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci U S A (1997) 1.82
Changes in clinical indications for community antibiotic prescribing for children in the UK from 1996 to 2006: will the new NICE prescribing guidance on upper respiratory tract infections just be ignored? Arch Dis Child (2008) 1.80
Situational norms for drinking and drunkenness: trends in the US adult population, 1979-1990. Addiction (1997) 1.77
Quality of life and mental illness. Reflections from the perspective of the WHOQOL. Br J Psychiatry (1998) 1.73
Steps towards constructing a global comparative risk analysis for alcohol consumption: determining indicators and empirical weights for patterns of drinking, deciding about theoretical minimum, and dealing with different consequences. Eur Addict Res (2001) 1.73
Prevalence of mental illness in Germany and the United States. Comparison of the Upper Bavarian Study and the Epidemiologic Catchment Area Program. J Nerv Ment Dis (1996) 1.70
Towards agreement on ways to measure and report drinking patterns and alcohol-related problems in adult general population surveys: the Skarpö conference overview. J Subst Abuse (2000) 1.69
The relative risks and etiologic fractions of different causes of death and disease attributable to alcohol, tobacco and illicit drug use in Canada. CMAJ (2000) 1.68
Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2011) 1.67
Moderate drinking and health: report of an international symposium. CMAJ (1994) 1.65
Perceived condom norms and HIV risks among social and sexual networks of young African American men who have sex with men. Health Educ Res (2008) 1.65
Relation between average alcohol consumption and disease: an overview. Eur Addict Res (2001) 1.62
Trends in the treatment of alcohol problems in the US general population, 1979 through 1990. Am J Public Health (1995) 1.61
On the emerging paradigm of drinking patterns and their social and health consequences. Addiction (1996) 1.60
HIV risk behaviors associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks. Subst Use Misuse (1998) 1.58
Adrenodoxin reductase homolog (Arh1p) of yeast mitochondria required for iron homeostasis. J Biol Chem (2001) 1.57
CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J Vasc Res (2003) 1.56
Privatizing alcohol sales and alcohol consumption: evidence and implications. Addiction (1999) 1.54
The Mennen femoral plate for fixation of periprosthetic femoral fractures following hip arthroplasty. Injury (2002) 1.53
The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992. Addiction (1998) 1.53
Current directions in research on understanding and preventing intoxicated aggression. Addiction (1998) 1.53
Injection drug use and preventive measures: a comparison of Canadian and western European jurisdictions over time. CMAJ (2000) 1.52
Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res (1999) 1.51
Trends in mortality from suicide, 1965-99. Acta Psychiatr Scand (2003) 1.50
Moderate drinking and health. Implications of recent evidence. Can Fam Physician (1997) 1.50
Mitochondrial translocation of protein kinase C delta in phorbol ester-induced cytochrome c release and apoptosis. J Biol Chem (2000) 1.48
Time to act on headache disorders. J Headache Pain (2011) 1.47
Low-risk drinking guidelines: the scientific evidence. Can J Public Health (1999) 1.43
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Preliminary development of the World Health Organsiation's Quality of Life HIV instrument (WHOQOL-HIV): analysis of the pilot version. Soc Sci Med (2003) 1.40
The U.S. general population's experiences of responding to alcohol problems. Br J Addict (1989) 1.39
Some reflections on the relationship of risk, harm and responsibility in recent tobacco lawsuits, and implications for public health. Can J Public Health (2001) 1.39
Upper and lower limb standards in newborn. Indian Pediatr (1989) 1.38
The risk environment for HIV transmission: results from the Atlanta and Flagstaff network studies. J Urban Health (2001) 1.37
Alcohol consumption as a risk factor for pneumonia: a systematic review and meta-analysis. Epidemiol Infect (2010) 1.36
Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys. Mol Psychiatry (2010) 1.36
Are disability weights universal? WHO/NIH Joint Project CAR Study Group. Lancet (1999) 1.36
Preliminary report of psychiatric disorders in survivors of a severe earthquake. Am J Psychiatry (1996) 1.35
Kerosene abuse by inhalation and ingestion. Am J Psychiatry (1992) 1.35
Targeting of the c-Abl tyrosine kinase to mitochondria in endoplasmic reticulum stress-induced apoptosis. Mol Cell Biol (2001) 1.33
Targeting of protein kinase C delta to mitochondria in the oxidative stress response. Cell Growth Differ (2001) 1.31
Epithelial stem cells in the skin: definition, markers, localization and functions. Exp Dermatol (1999) 1.29
Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol Psychiatry (2001) 1.28
Targeting of the c-Abl tyrosine kinase to mitochondria in the necrotic cell death response to oxidative stress. J Biol Chem (2001) 1.21
Issues related to disability in India: a focus group study. Natl Med J India (2001) 1.20
Charting WHO--goals for licit and illicit drugs for the year 2000: are we 'on track'? Public Health (1997) 1.17
Headache disorders in developing countries: research over the past decade. Cephalalgia (2008) 1.16
Cultural contingencies of alcoholism: variations between and within nineteenth-century urban ethnic groups in alcohol-related death rates. J Health Soc Behav (1968) 1.15
Cross-cultural applicability in international classifications and research on alcohol dependence. J Stud Alcohol (1999) 1.14
Stress fracture of the pubic ramus in female recruits. J Bone Joint Surg Br (1996) 1.13
Limitations of diagnostic paradigm: it doesn't explain "need". Arch Gen Psychiatry (1998) 1.13
Autoimmune hemolytic anemia with both cold and warm autoantibodies. JAMA (1985) 1.13
High viable cell concentration fed-batch cultures of hybridoma cells through on-line nutrient feeding. Biotechnol Bioeng (1995) 1.13
Prefrontal-subcortical and limbic circuit mediation of major depressive disorder. Semin Clin Neuropsychiatry (2001) 1.12
Alcohol control and public health. Annu Rev Public Health (1984) 1.11